CA2887830A1 - Polymorphismes genetiques associes a des techniques de detection de cirrhose du foie et utilisation de ces polymorphismes - Google Patents

Polymorphismes genetiques associes a des techniques de detection de cirrhose du foie et utilisation de ces polymorphismes Download PDF

Info

Publication number
CA2887830A1
CA2887830A1 CA2887830A CA2887830A CA2887830A1 CA 2887830 A1 CA2887830 A1 CA 2887830A1 CA 2887830 A CA2887830 A CA 2887830A CA 2887830 A CA2887830 A CA 2887830A CA 2887830 A1 CA2887830 A1 CA 2887830A1
Authority
CA
Canada
Prior art keywords
dna
homo sapiens
seq
nucleic acid
human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2887830A
Other languages
English (en)
Other versions
CA2887830C (fr
Inventor
Michele Cargill
Hongjin Huang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Celera Corp
Original Assignee
Celera Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Celera Corp filed Critical Celera Corp
Priority claimed from CA2852855A external-priority patent/CA2852855C/fr
Publication of CA2887830A1 publication Critical patent/CA2887830A1/fr
Application granted granted Critical
Publication of CA2887830C publication Critical patent/CA2887830C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

La présente invention concerne la découverte que des polymorphismes génétiques sont associés à la cirrhose et à des pathologies associées. Cette invention concerne en particulier des molécules dacides nucléiques contenant ces polymorphismes, des protéines de variant codées par ces molécules dacides nucléiques, des réactifs permettant de détecter ces molécules et ces protéines dacides nucléiques polymorphiques, des techniques dutilisation de ces acides nucléiques et de ces protéines ainsi que des techniques dutilisation de réactifs qui permettent leur détection.
CA2887830A 2004-05-07 2005-05-09 Polymorphismes genetiques associes a des techniques de detection de cirrhose du foie et utilisation de ces polymorphismes Expired - Lifetime CA2887830C (fr)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US56884604P 2004-05-07 2004-05-07
US60/568,846 2004-05-07
US58260904P 2004-06-25 2004-06-25
US60/582,609 2004-06-25
US59955404P 2004-08-09 2004-08-09
US60/599,554 2004-08-09
CA2852855A CA2852855C (fr) 2004-05-07 2005-05-09 Polymorphismes genetiques associes a des techniques de detection de cirrhose du foie et utilisation de ces polymorphismes

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA2852855A Division CA2852855C (fr) 2004-05-07 2005-05-09 Polymorphismes genetiques associes a des techniques de detection de cirrhose du foie et utilisation de ces polymorphismes

Publications (2)

Publication Number Publication Date
CA2887830A1 true CA2887830A1 (fr) 2005-11-24
CA2887830C CA2887830C (fr) 2017-06-20

Family

ID=49253575

Family Applications (3)

Application Number Title Priority Date Filing Date
CA2826522A Expired - Lifetime CA2826522C (fr) 2004-05-07 2005-05-09 Polymorphisme genetique dans pnpla3 associe aux procedes de detection d'une fibrose du foie et leurs utilisations
CA2837792A Expired - Lifetime CA2837792C (fr) 2004-05-07 2005-05-09 Polymorphisme genetique de lrp5 associe aux procedes de detection de la fibrose du foie et ses utilisations
CA2887830A Expired - Lifetime CA2887830C (fr) 2004-05-07 2005-05-09 Polymorphismes genetiques associes a des techniques de detection de cirrhose du foie et utilisation de ces polymorphismes

Family Applications Before (2)

Application Number Title Priority Date Filing Date
CA2826522A Expired - Lifetime CA2826522C (fr) 2004-05-07 2005-05-09 Polymorphisme genetique dans pnpla3 associe aux procedes de detection d'une fibrose du foie et leurs utilisations
CA2837792A Expired - Lifetime CA2837792C (fr) 2004-05-07 2005-05-09 Polymorphisme genetique de lrp5 associe aux procedes de detection de la fibrose du foie et ses utilisations

Country Status (1)

Country Link
CA (3) CA2826522C (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109811061B (zh) * 2019-02-20 2023-05-09 新疆农业大学 Coil基因特异snp标记、和田乔达红羊产羔数性状的检测方法及其应用
CN113674804A (zh) * 2021-09-09 2021-11-19 安吉康尔(深圳)科技有限公司 一种批量构建和筛选重组质粒的方法

Also Published As

Publication number Publication date
CA2826522C (fr) 2016-04-12
CA2837792C (fr) 2016-07-05
CA2837792A1 (fr) 2005-11-24
CA2887830C (fr) 2017-06-20
CA2826522A1 (fr) 2005-11-24

Similar Documents

Publication Publication Date Title
US20250041457A1 (en) Use of adeno-associated viral vectors to correct gene defects/ express proteins in hair cells and supporting cells in the inner ear
KR20220062517A (ko) 결합 변형된 올리고머 화합물 및 이의 용도
KR102149483B1 (ko) 예측변수 인자들을 이용하여 동정된 환자 부분 모집단에서 암 치료를 위한 마시티닙의 용도
CN109476698B (zh) 基于基因的炎性肠病诊断
CA2886504A1 (fr) Polymorphismes wdr12 associes a l'infarctus du myocarde, methodes de detection et utilisations associees
KR20220012230A (ko) 스플라이싱 및 번역을 조절하기 위한 방법 및 조성물
US20090305284A1 (en) Methods for Identifying Risk of Breast Cancer and Treatments Thereof
CN107223159A (zh) 源自特定细胞类型的dna的检测及相关方法
KR20130123357A (ko) 저산소증과 관련된 질환의 진단방법 및 키트
KR20180049093A (ko) 신규한 바이오마커 및 암의 치료 방법
WO2006022629A1 (fr) Procédés d’identification de risque de diabète de type ii et leurs traitements
KR20090087486A (ko) 타입 2 당뇨병의 유전적 감수성 변이
CN101631876A (zh) 2型糖尿病的遗传易感性变体
KR20060045950A (ko) 혈액학적 악성종양에 대한 예후
AU2023203393A1 (en) Compositions and methods for screening and identifying clinically aggressive prostate cancer
AU2018360287B2 (en) Method for determining the response of a malignant disease to an immunotherapy
WO2006022636A1 (fr) Méthodes d’identification du risque d’apparition de diabètes de type ii et traitements associés
WO2006022634A1 (fr) Méthodes d’identification du risque d’apparition de diabètes de type ii et traitements associés
KR102642320B1 (ko) 항암제에 대한 내성 진단용 조성물
IL179831A (en) In vitro method for detecting the presence of or predisposition to autism or to an autism spectrum disorder, and an in vitro method of selecting biologically active compounds on autism or autism spectrum disorders
WO2006022638A1 (fr) Méthodes d’identification du risque d’apparition de diabètes de type ii et traitements associés
WO2018209358A2 (fr) Administration systémique de polypeptides
CA2887830A1 (fr) Polymorphismes genetiques associes a des techniques de detection de cirrhose du foie et utilisation de ces polymorphismes
KR20150094601A (ko) 성별에 독립적인 연령 결정 방법
KR20130024137A (ko) 묘안 증후군 진단용 마이크로어레이 및 키트

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20150515

H13 Ip right lapsed

Free format text: ST27 STATUS EVENT CODE: N-4-6-H10-H13-H100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE AND LATE FEE NOT PAID BY DEADLINE OF NOTICE

Effective date: 20251106